Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound

World |  News | 0 Comment | 09 Sep, 2019

Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as a potential targe...Read more

Schrödinger, AstraZeneca join hands to accelerate drug dicovery

World |  News | 0 Comment | 05 Sep, 2019

Schrödinger, scientific leader in developing state-of-the-art chemical simulation software, has announced a collaboration with AstraZeneca to deploy Schrödinger’s ...Read more

Mundipharma, Cidara ink $568M deal for antifungal treatment

World |  News | 0 Comment | 04 Sep, 2019

Cidara Therapeutics, Inc. and Mundipharma have announced that they have entered into a strategic partnership to develop and commercialize rezafungin for the treatment and prevention of inva...Read more

Velabs Therapeutics partners with alytas for obesity treatment

World |  News | 0 Comment | 03 Sep, 2019

Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional therapeutic antibodies, has announces that it has entered into a partnership agreement...Read more

Abbott unveils new detection platform in Brazil

World |  News | 0 Comment | 02 Sep, 2019

Abbott, a global health care company, launches in Brazil its ID NOW ™point of care molecular platform with tests for the rapid detection of respiratory diseases su...Read more

SC Johnson Spatial repellent innovation provides potential solution for malaria

World |  News | 0 Comment | 30 Aug, 2019

The World Health Organization (WHO) recently posted a report showing the effectiveness of spatial repellents in fighting malaria. The data outcomes came from the first study of a five-year ...Read more

BioCity invests in early-stage precision medicine biotech

World |  News | 0 Comment | 29 Aug, 2019

BioCity, the pioneering life science incubator and business collective, on 29 August 2019, announced an investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precisio...Read more

Crozet partners with PHV to develop Nipah virus vaccine

World |  News | 0 Comment | 28 Aug, 2019

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (PHV), to advance the development and manufacture of a vaccine against ...Read more

Harbour BioMed, PPD partner for oncology and immunology

World |  News | 0 Comment | 28 Aug, 2019

Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company, and Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), ...Read more

FDA fast tracks AstraZeneca's FARXIGA

World |  News | 0 Comment | 28 Aug, 2019

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to delay the progression of renal ...Read more

Global Neurorehabilitation devices market to be worth $3.2B by 2024

World |  News | 0 Comment | 28 Aug, 2019

The global Neurorehabilitation Devices Market is foreseen to project a notable growth because of the rising prevalence of neurological illnesses. Rising cases of neurological diso...Read more

FDA approves new add-on drug to treat Parkinson's disease

World |  News | 0 Comment | 28 Aug, 2019

The U.S. Food and Drug Administration, on 27 August 2019, approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson's disease ...Read more

KPMG, Thermo Fisher to work on gene interaction with medicines

World |  News | 0 Comment | 28 Aug, 2019

KPMG's Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with pharmacogenomics data – information about how genes interact with...Read more

Studies shows critically ill patients use Masimo ORi to reduce hyperoxia

World |  News | 0 Comment | 27 Aug, 2019

Masimo, on 27 August 2019, announced the latest publication of a report on 150 randomized controlled trials of ICU patients in Intensive Care Medicine. Researchers evaluated with pure ...Read more

Agilent Completes Acquisition of BioTek Instruments

World |  News | 0 Comment | 27 Aug, 2019

Agilent Technologies has announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumenta...Read more

GE's Drawbridge Health Receives FDA nod for blood testing system

World |  News | 0 Comment | 27 Aug, 2019

Drawbridge Health, Founded in 2015 by GE Ventures and GE Healthcare, Drawbridge Health is a healthcare technology company  has announced that it has received 510(k) clearance...Read more

Amgen buys Celgene's OTEZLA for $13.4 Bn

World |  News | 0 Comment | 27 Aug, 2019

Bristol-Myers Squibb Company has announced that Celgene Corporation  in connection with its merger agreement with Bristol-Myers Squibb, has entered into an agreement with Amgen  u...Read more

Gilead, Galapagos close their development collaboration

World |  News | 0 Comment | 26 Aug, 2019

Gilead Sciences and Galapagos have announced the closing of the global research and development collaboration agreement signed on July 14, 2019. This agreement has received clearance from ...Read more